427 related articles for article (PubMed ID: 31889409)
1. Current and emerging therapies for managing hyperphagia and obesity in Prader-Willi syndrome: A narrative review.
Tan Q; Orsso CE; Deehan EC; Triador L; Field CJ; Tun HM; Han JC; Müller TD; Haqq AM
Obes Rev; 2020 May; 21(5):e12992. PubMed ID: 31889409
[TBL] [Abstract][Full Text] [Related]
2. Peptides associated with hyperphagia in adults with Prader-Willi syndrome before and during GH treatment.
Höybye C; Barkeling B; Espelund U; Petersson M; Thorén M
Growth Horm IGF Res; 2003 Dec; 13(6):322-7. PubMed ID: 14624765
[TBL] [Abstract][Full Text] [Related]
3. Effects of exenatide on weight and appetite in overweight adolescents and young adults with Prader-Willi syndrome.
Salehi P; Hsu I; Azen CG; Mittelman SD; Geffner ME; Jeandron D
Pediatr Obes; 2017 Jun; 12(3):221-228. PubMed ID: 27071367
[TBL] [Abstract][Full Text] [Related]
4. Prader-Willi Syndrome: Possibilities of Weight Gain Prevention and Treatment.
Erhardt É; Molnár D
Nutrients; 2022 May; 14(9):. PubMed ID: 35565916
[TBL] [Abstract][Full Text] [Related]
5. Elevated ratio of acylated to unacylated ghrelin in children and young adults with Prader-Willi syndrome.
Kuppens RJ; Diène G; Bakker NE; Molinas C; Faye S; Nicolino M; Bernoux D; Delhanty PJ; van der Lely AJ; Allas S; Julien M; Delale T; Tauber M; Hokken-Koelega AC
Endocrine; 2015 Dec; 50(3):633-42. PubMed ID: 25989955
[TBL] [Abstract][Full Text] [Related]
6. Hyperghrelinemia in Prader-Willi syndrome begins in early infancy long before the onset of hyperphagia.
Kweh FA; Miller JL; Sulsona CR; Wasserfall C; Atkinson M; Shuster JJ; Goldstone AP; Driscoll DJ
Am J Med Genet A; 2015 Jan; 167A(1):69-79. PubMed ID: 25355237
[TBL] [Abstract][Full Text] [Related]
7. Behavioral changes in patients with Prader-Willi syndrome receiving diazoxide choline extended-release tablets compared to the PATH for PWS natural history study.
Strong TV; Miller JL; McCandless SE; Gevers E; Yanovski JA; Matesevac L; Bohonowych J; Ballal S; Yen K; Hirano P; Cowen NM; Bhatnagar A
J Neurodev Disord; 2024 Apr; 16(1):22. PubMed ID: 38671361
[TBL] [Abstract][Full Text] [Related]
8. High circulating ghrelin: a potential cause for hyperphagia and obesity in prader-willi syndrome.
DelParigi A; Tschöp M; Heiman ML; Salbe AD; Vozarova B; Sell SM; Bunt JC; Tataranni PA
J Clin Endocrinol Metab; 2002 Dec; 87(12):5461-4. PubMed ID: 12466337
[TBL] [Abstract][Full Text] [Related]
9. Prader Willi Syndrome: Genetics, Metabolomics, Hormonal Function, and New Approaches to Therapy.
Irizarry KA; Miller M; Freemark M; Haqq AM
Adv Pediatr; 2016 Aug; 63(1):47-77. PubMed ID: 27426895
[No Abstract] [Full Text] [Related]
10. What is the value of growth hormone therapy in Prader Willi syndrome?
Bridges N
Arch Dis Child; 2014 Feb; 99(2):166-70. PubMed ID: 24162007
[TBL] [Abstract][Full Text] [Related]
11. Disentangling ingestive behavior-related phenotypes in Prader-Willi syndrome: Integrating information from nonclinical studies and clinical trials to better understand the pathophysiology of hyperphagia and obesity.
Wevrick R
Physiol Behav; 2020 May; 219():112864. PubMed ID: 32156555
[TBL] [Abstract][Full Text] [Related]
12. EFFECT OF GROWTH HORMONE THERAPY IN CHILDREN WITH PRADER-WILLI SYNDROME - OUR FIRST EXPERIENCES.
Stipančić G; Požgaj Šepec M; La Grasta Sabolić L
Acta Clin Croat; 2018 Dec; 57(4):744-755. PubMed ID: 31168212
[TBL] [Abstract][Full Text] [Related]
13. Ghrelin concentrations in Prader-Willi syndrome (PWS) infants and children: changes during development.
Haqq AM; Grambow SC; Muehlbauer M; Newgard CB; Svetkey LP; Carrel AL; Yanovski JA; Purnell JQ; Freemark M
Clin Endocrinol (Oxf); 2008 Dec; 69(6):911-20. PubMed ID: 18710462
[TBL] [Abstract][Full Text] [Related]
14. Intranasal carbetocin reduces hyperphagia in individuals with Prader-Willi syndrome.
Dykens EM; Miller J; Angulo M; Roof E; Reidy M; Hatoum HT; Willey R; Bolton G; Korner P
JCI Insight; 2018 Jun; 3(12):. PubMed ID: 29925684
[TBL] [Abstract][Full Text] [Related]
15. Appetite hormones and the transition to hyperphagia in children with Prader-Willi syndrome.
Goldstone AP; Holland AJ; Butler JV; Whittington JE
Int J Obes (Lond); 2012 Dec; 36(12):1564-70. PubMed ID: 22270375
[TBL] [Abstract][Full Text] [Related]
16. Transcranial direct current stimulation reduces food-craving and measures of hyperphagia behavior in participants with Prader-Willi syndrome.
Bravo GL; Poje AB; Perissinotti I; Marcondes BF; Villamar MF; Manzardo AM; Luque L; LePage JF; Stafford D; Fregni F; Butler MG
Am J Med Genet B Neuropsychiatr Genet; 2016 Mar; 171B(2):266-75. PubMed ID: 26590516
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of obesity in Prader-Willi syndrome.
Khan MJ; Gerasimidis K; Edwards CA; Shaikh MG
Pediatr Obes; 2018 Jan; 13(1):3-13. PubMed ID: 27863129
[TBL] [Abstract][Full Text] [Related]
18. In adults with Prader-Willi syndrome, elevated ghrelin levels are more consistent with hyperphagia than high PYY and GLP-1 levels.
Purtell L; Sze L; Loughnan G; Smith E; Herzog H; Sainsbury A; Steinbeck K; Campbell LV; Viardot A
Neuropeptides; 2011 Aug; 45(4):301-7. PubMed ID: 21722955
[TBL] [Abstract][Full Text] [Related]
19. Understanding the causes of obesity in children with trisomy 21: hyperphagia vs physical inactivity.
Foerste T; Sabin M; Reid S; Reddihough D
J Intellect Disabil Res; 2016 Sep; 60(9):856-64. PubMed ID: 26936540
[TBL] [Abstract][Full Text] [Related]
20. Children with Prader-Willi syndrome exhibit more evident meal-induced responses in plasma ghrelin and peptide YY levels than obese and lean children.
Bizzarri C; Rigamonti AE; Luce A; Cappa M; Cella SG; Berini J; Sartorio A; Müller EE; Salvatoni A
Eur J Endocrinol; 2010 Mar; 162(3):499-505. PubMed ID: 20019130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]